Harmonised Filing System For Plant Variety Protection Discussed At UPOV 16/04/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment An industry proposal calling for a harmonised procedure to simplify applications for new varieties of plants and heighten intellectual property protection stirred debate at the International Union for the Protection of New Varieties of Plants (UPOV) last month.
Experts Debate Medicines Access In South Africa And Beyond 15/04/2015 by Linda Daniels for Intellectual Property Watch 2 Comments CAPE TOWN – Pharmaceutical patents and access to medicines was the focus of an animated panel discussion by experts offering divergent views on the topic at intellectual property group FICPI’s 2015 World Congress, currently underway in Cape Town, South Africa.
Council Of Europe Holds Consultations On Draft Internet Freedom Text 14/04/2015 by William New, Intellectual Property Watch Leave a Comment A committee of the Strasbourg-based Council of Europe is drafting a recommendation on internet freedom and is requesting public comments until the end of the month.
Don’t Keep The Trans-Pacific Partnership Talks Secret 14/04/2015 by William New, Intellectual Property Watch Leave a Comment [From the New York Times Opinion pages, by Margot Kaminski:] COLUMBUS, Ohio — WHEN WikiLeaks recently released a chapter of the Trans-Pacific Partnership Agreement, critics and proponents of the deal resumed wrestling over its complicated contents. But a cover page of the leaked document points to a different problem: It announces that the draft text is classified by the United States government. Even if current negotiations over the trade agreement end with no deal, the draft chapter will still remain classified for four years as national security information. The initial version of an agreement projected by the government to affect millions of Americans will remain a secret until long after meaningful public debate is possible. [Note: article mentions a US FOIA case by IP-Watch]
Clinical Trial Transparency, Medicines Access On Agendas Today 14/04/2015 by William New, Intellectual Property Watch Leave a Comment The World Health Organization today issued a call for disclosure of results from clinical trials for medical products, no matter what the results of the trials were. And a variety of events and publications are addressing medicines access today.
A Global Digital Magna Carta? Maybe, But First Identify Needs, Panel Says 13/04/2015 by William New, Intellectual Property Watch Leave a Comment NEW YORK – A recent panel of internet governance experts was divided on whether a primary global set of principles protecting the balance of power on the internet is needed.
Whistleblowers: Little UN Protection For Exposing Wrongdoing 10/04/2015 by William New, Intellectual Property Watch 2 Comments From AP: High-profile whistleblowers have joined forces for the first time in demanding that the United Nations change a global system they say deters its thousands of staffers from exposing crime, corruption and other wrongdoing. In a letter sent to Secretary-General Ban Ki-moon on Wednesday, nine current and former U.N. workers say current policies offer “little to no measure of real or meaningful protection” from retaliation that can include firing, harassment and intimidation.
EPO Backs Patents On Conventional Plants: Broccoli, Tomato Cases Decided 01/04/2015 by Catherine Saez, Intellectual Property Watch 12 Comments The highest court of the European Patent Office has declared that plants or seeds obtained through conventional breeding methods are patentable.
Panel: Open Data, Open Access, And Open Education – Key To Open Innovation? 31/03/2015 by Elena Bourtchouladze for Intellectual Property Watch 1 Comment Intellectual property stimulates creativity but at the same time holds back innovation, speakers said at a recent event on open innovation and alternative business models. The roundtable looked a range of models, such as open source and open data, and their advantages, to “all rights reserved” protection.
Supplier of Essential Medicines Supports TRIPS Waiver For Least-Developed Countries 30/03/2015 by Catherine Saez, Intellectual Property Watch 5 Comments The IDA Foundation, a worldwide supplier of essential medicines to low-and medium income countries, has backed the request by least-developed countries to extend a waiver that allows them to forfeit the obligations to protect intellectual property on pharmaceutical products. UNITAID, the UN-related drug purchasing mechanism, also issued a statement in support of the extension. The request is expected to be discussed at the World Trade Organization in June.